A Randomized, Phase II Study of Concurrent Radiotherapy and Oxaliplatin, Capecitabine With or Without Cetuximab in Rectal Cancer Tumor Stratified by KRAS Mutation Status.
Phase of Trial: Phase II
Latest Information Update: 15 Jan 2014
At a glance
- Drugs Cetuximab (Primary) ; Capecitabine; Oxaliplatin
- Indications Rectal cancer
- Focus Therapeutic Use
- 15 Jan 2014 Planned End Date changed to 1 Dec 2014 as reported by ClinicalTrials.gov record
- 02 Dec 2008 New trial record.